|By Business Wire||
|August 4, 2014 09:01 AM EDT||
Life science market intelligence company, Evaluate, Ltd., announced today that Founder and CEO, Dr. Jonathan de Pass, has been selected by PharmaVOICE magazine as one of the top 100 most inspirational and influential people in the Life Sciences Industry.
The PharmaVOICE 100 represents leaders from across the global life sciences industry. A panel of PharmaVOICE editors chose the winners based on their ability to inspire, motivate and influence corporate leadership, research and development, technology, creativity and marketing and strategy.
Dr. de Pass founded Evaluate, Ltd. and the EvaluatePharma service from the ground up in 1996. Since then, Evaluate has come to be regarded as a trusted leader in life science market intelligence, known for its expertise, creativity and customer service by most of the world’s global pharmaceutical companies. A career highlight for Dr. de Pass was winning the Queens Award for Enterprise in 2009, one of the UK’s most prestigious business awards.
“For the 10 years I have worked with Jonathan, he has not only motivated me to always improve the way we manage and grow our services but has been an excellent person to work alongside, learn from and most importantly be inspired by,” said Debbie Paul, CEO, EvaluatePharma USA, Inc.
To read the 2014 PharmaVOICE 100 profiles, visit www.pharmavoice.com.
About Evaluate Ltd.
Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2020. We support life science and healthcare companies, financial institutions, consultancies and service providers in their strategic decision-making. Our services include EvaluatePharma, EvaluateClinical Trials and EvaluateMedTech. Our global team of dedicated healthcare analysts employs rigorous methodologies to deliver strategic commercial analysis. We make our services valuable by combining superior quality content, user-friendly reporting tools and outstanding customer service to solve client problems. Our award-winning editorial team, EP Vantage, leverages our market intelligence and analysis to cut through the noise, giving you daily opinion and insights. The Evaluate services enable the life science community to make sound business decisions about value and opportunity. For more information please visit www.evaluategroup.com. On Twitter: @evaluatepharma, @evaluatemedtech, @epclinicaltrial, @epvantage.
Dec. 3, 2016 06:15 PM EST Reads: 1,500
Dec. 3, 2016 05:30 PM EST Reads: 4,027
Dec. 3, 2016 05:15 PM EST Reads: 2,129
Dec. 3, 2016 05:15 PM EST Reads: 1,991
Dec. 3, 2016 04:30 PM EST Reads: 1,460
Dec. 3, 2016 04:00 PM EST Reads: 4,852
Dec. 3, 2016 03:30 PM EST Reads: 1,578
Dec. 3, 2016 03:15 PM EST Reads: 3,215
Dec. 3, 2016 03:00 PM EST Reads: 462
Dec. 3, 2016 02:45 PM EST Reads: 509
Dec. 3, 2016 02:45 PM EST Reads: 707
Dec. 3, 2016 02:45 PM EST Reads: 779
Dec. 3, 2016 02:45 PM EST Reads: 670
Dec. 3, 2016 02:15 PM EST Reads: 6,949
Dec. 3, 2016 02:00 PM EST Reads: 2,477